Identification of HTF (HER2 transcription factor) as an AP-2 (activator protein-2) transcription factor and contribution of the HTF binding site to ERBB2 gene overexpression
- 15 February 2003
- journal article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 370 (1) , 323-329
- https://doi.org/10.1042/bj20021238
Abstract
The ERBB2 gene is overexpressed in 30% of human breast cancers and this is correlated with poor prognosis. Overexpression of the ERBB2 gene is due to increased transcription and gene amplification. Our previous studies have identified a new cis element in the ERBB2 promoter which is involved in the gene's overexpression. This cis element, located 501bp upstream from the main ERBB2 transcription initiation site, binds a transcription factor called HTF (HER2 transcription factor). We report here the identification of HTF as an AP-2 (activator protein-2) transcription factor. The new cis element is bound by AP-2 with high affinity, compared with a previously described AP-2 binding site located 284bp downstream. Co-transfection of an AP-2α expression vector with a reporter vector containing the newly identified AP-2 binding site in front of a minimal ERBB2 promoter induced a dose-dependent increase in transcriptional activity. We examined the contribution of the new AP-2 binding site to ERBB2 overexpression. For this purpose we abolished the new and/or the previously described AP-2 binding sequence by site-directed mutagenesis. The results show that the two functional AP-2 sites in the first 700bp of the ERBB2 promoter co-operate to achieve maximal transcriptional activity.Keywords
This publication has 24 references indexed in Scilit:
- Update on HER-2 as a target for cancer therapy: The ERBB2 promoter and its exploitation for cancer treatmentBreast Cancer Research, 2001
- SELEX and missing phosphate contact analyses reveal flexibility within the AP-2 protein:DNA binding complexNucleic Acids Research, 1999
- A new cis element is involved in the HER2 gene overexpression in human breast cancer cells.1999
- Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways.1998
- A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma.1996
- Activation of Epidermal Growth Factor Receptor Gene Transcription by Phorbol 12-Myristate 13-Acetate Is Mediated by Activator Protein 2Journal of Biological Chemistry, 1996
- The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma.Proceedings of the National Academy of Sciences, 1995
- The 6-kilobase c-erbB2 promoter contains positive and negative regulatory elements functional in human mammary cell lines.1994
- A novel transcription factor, OB2-1, is required for overexpression of the proto-oncogene c-erbB-2 in mammary tumour lines.1993
- Analysis of the DNA-binding and activation properties of the human transcription factor AP-2.Genes & Development, 1991